Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?
Metalloproteinases In Medicine · 2016
DOI: 10.2147/mnm.s102209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metalloproteinases In Medicine, 2016. Verfasst von Patrick Henriet und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Henriet, P., Mon, K. S., & Marbaix, E. (2016). Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?. Metalloproteinases In Medicine. https://doi.org/10.2147/mnm.s102209
Vancouver
Henriet P, Mon KS, Marbaix E. Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?. Metalloproteinases In Medicine. 2016. doi:10.2147/mnm.s102209
BibTeX
@article{Henriet2016,
author = {Henriet, Patrick and Mon, Khin Su and Marbaix, Etienne},
title = {Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?},
journal = {Metalloproteinases In Medicine},
year = {2016},
doi = {10.2147/mnm.s102209}
}
EUVIMED